The clinical study suggests that the Roche pre-eclampsia test can determine which women will, and will not, develop pre-eclampsia within the next few weeks.
Authors of the study believe the test could prevent hospitalisation by up to 50% and create savings in the health care system.
The Director of the Royal College of Midwives, Louise Silverton, said that the test is a step in the right direction for antenatal care.
“The latest study is indeed interesting, being able to foresee, if a mother may be at risk of developing pre-eclampsia marks a positive step forward for antenatal care.
“Pre-eclampsia is a common condition in pregnancy which in its mild stages can be managed. However, it does need to be taken very seriously because in its severe form pre-eclampsia can have serious and harmful effects on the mother and baby. The only effective treatment is to deliver the baby and if severe pre-eclampsia occurs before term, the baby also has risks of prematurity to add to any growth problems that may have occurred,” she said.
Keep up to date with the latest news from MIDIRS by signing up to our e-newsletter. Sign-up